Publications by authors named "Martin Yardley"
Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
Mult Scler Relat Disord
January 2019
Article Synopsis
- The study evaluated the long-term effectiveness and safety of intrathecal baclofen (ITB) for treating spasticity related to multiple sclerosis (MS) over approximately 20 years.
- A total of 106 subjects were involved, and results showed significant improvements in spasticity and pain scores post-treatment, with many patients able to stop oral antispasticity medications.
- Complication rates were low, mostly mechanical, and a notable percentage of those who could walk before the treatment maintained their ability to do so after one year, suggesting ITB may be a beneficial early intervention.